SuperworthBIO-TECHNE shares outstanding TECH
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 30, 2026
- 157.2M
- On a year earlier
- +1.0%
- more shares
BIO-TECHNE had 157.2M diluted shares outstanding on average in Q4 FY26, the quarter to Jun 30, 2026.
That is 1.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 157.2M | +1% |
| FY2025 | 155.7M | −3% |
| FY2024 | 160.6M | −1% |
| FY2023 | 162.1M | −1% |
| FY2022 | 163.6M | −0% |
| FY2021 | 164.1M | +3% |
| FY2020 | 158.8M | +1% |
| FY2019 | 156.5M | +2% |
| FY2018 | 153.4M | +2% |
| FY2017 | 150.2M | +0% |
| FY2016 | 149.5M | +0% |
| FY2015 | 149.2M | +1% |
| FY2014 | 148.1M | +0% |
| FY2013 | 147.6M | +0% |
| FY2012 | 147.6M | −1% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 157.2M | +1% | |
| Q3 FY26 | 157.4M | −1% | |
| Q2 FY26 | 157M | −2% | |
| Q1 FY26 | 156.4M | −3% | |
| Q4 FY25 | 155.7M | −3% | |
| Q3 FY25 | 158.9M | −1% | |
| Q2 FY25 | 160.6M | +0% | |
| Q1 FY25 | 161.1M | −1% | |
| Q4 FY24 | 160.6M | −1% | |
| Q3 FY24 | 160.5M | −1% | |
| Q2 FY24 | 160.1M | −1% | |
| Q1 FY24 | 161.9M | −0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on BIO-TECHNE
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.